Implementation of an Integrated Infectious Disease and Substance Use Disorder Team for Injection Drug Use-associated Infections (DA2338)
Pre-Approved for: ACM, CA BRN, CCAPP, CE Broker Provider, Delaware BON, FCB, MCBAP-Specific , NAADAC, RNs
Credit Hours: 3
This course is online. All course material is available online and is accessible immediately after purchase from your account homepage. Certificate of Completion is available immediately upon passing the exam.
This course is the BioMed Central qualitative study for implementing infectious disease and substance use disorder teams to provide integrated care for people who misuse substances via injection. This study shows that utilizing severe injection-related infection staff is a promising approach to managing patients for better outcomes and the importance of follow-up care.
- Identify significant barriers for people who inject drugs to receive appropriate care and treatment.
- Analyze data for best practice interventions to introduce into care settings and educate healthcare staff about approaches to patients who inject substances.
- Implement appropriate interventions and invite patient feedback to continue improving care approaches or making necessary adjustments for better outcomes.
- Monitor staff-to-patient interactions to de-escalate stigma and provide quality care, including follow-up communications.
Appendix A - Clinician Interview Guide
Appendix B - Patient Interview Guide